Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Clinical Pharmacology of Piperacillin/Tazobactam

View through CrossRef
Piperacillin extends the spectrum of activity of ampicillin to include most strains of Pseudomonas aeruginosa, Enterobacteriaceae (non-β-lactamase-producing), many Bacteroides species, and Escherichia faecalis. Combined with the β-lactamase inhibitor tazobactam, piperacillin/tazobactam has the broadest antibacterial spectrum of penicillins including activity against methicillin-susceptible Streptococcus aureus, Haemophilus influenzae, Bacillus fragilis, most Escherichia coli, and Klebsiella. Piperacillin is only available for parenteral administration. Piperacillin is an important agent for treatment of patients with serious infections caused by gram-negative bacteria including bacteraemias, pneumonias, infections following burns, and urinary-tract infections owing to microorganisms resistant to ampicillin and the bacteria responsible include Pseudomonas aeruginosa, indole-positive strains of Proteus, and Enterobacter species. The efficacy and safely of piperacillin/tazobactam have been reviewed and piperacillin and tazobactam concentrate in tissues in significant amounts. The elimination half-life of piperacillin and tazobactam is about 1 and 1.8 hours, respectively. The prophylaxis, treatment, and trials with piperacillin/tazobactam have been reviewed. Piperacillin/tazobactam may induce nephrotoxicity or neutropenia in some patients. The penetration of piperacillin into the central nervous system is good but tazobactam reaches concentrations in the cerebrospinal fluid inadequate to protect piperacillin by organisms producing β-lactamases and piperacillin/tazobactam treats bacterial meningitis. Piperacillin and tazobactam freely cross the human placenta. The aim of this study is to review piperacillin/ tazobactam efficacy and safely, prophylaxis, treatment, trials, treatment of meningitis, and piperacillin and tazobactam pharmacokinetics, penetration into the body-tissues and into the cerebrospinal fluid, transfer across the human placenta, and metabolism of piperacillin.
Title: Clinical Pharmacology of Piperacillin/Tazobactam
Description:
Piperacillin extends the spectrum of activity of ampicillin to include most strains of Pseudomonas aeruginosa, Enterobacteriaceae (non-β-lactamase-producing), many Bacteroides species, and Escherichia faecalis.
Combined with the β-lactamase inhibitor tazobactam, piperacillin/tazobactam has the broadest antibacterial spectrum of penicillins including activity against methicillin-susceptible Streptococcus aureus, Haemophilus influenzae, Bacillus fragilis, most Escherichia coli, and Klebsiella.
Piperacillin is only available for parenteral administration.
Piperacillin is an important agent for treatment of patients with serious infections caused by gram-negative bacteria including bacteraemias, pneumonias, infections following burns, and urinary-tract infections owing to microorganisms resistant to ampicillin and the bacteria responsible include Pseudomonas aeruginosa, indole-positive strains of Proteus, and Enterobacter species.
The efficacy and safely of piperacillin/tazobactam have been reviewed and piperacillin and tazobactam concentrate in tissues in significant amounts.
The elimination half-life of piperacillin and tazobactam is about 1 and 1.
8 hours, respectively.
The prophylaxis, treatment, and trials with piperacillin/tazobactam have been reviewed.
Piperacillin/tazobactam may induce nephrotoxicity or neutropenia in some patients.
The penetration of piperacillin into the central nervous system is good but tazobactam reaches concentrations in the cerebrospinal fluid inadequate to protect piperacillin by organisms producing β-lactamases and piperacillin/tazobactam treats bacterial meningitis.
Piperacillin and tazobactam freely cross the human placenta.
The aim of this study is to review piperacillin/ tazobactam efficacy and safely, prophylaxis, treatment, trials, treatment of meningitis, and piperacillin and tazobactam pharmacokinetics, penetration into the body-tissues and into the cerebrospinal fluid, transfer across the human placenta, and metabolism of piperacillin.

Related Results

Tazobactam selects for multidrug resistance
Tazobactam selects for multidrug resistance
Abstract Piperacillin-Tazobactam is a β-lactam/β-lactamase inhibitor combination that is amongst the most prescribed antimicrobials in hospital medicine. Piperacillin is ...
Tazobactam selects for multidrug resistance
Tazobactam selects for multidrug resistance
Abstract Piperacillin-Tazobactam is a β-lactam/β-lactamase inhibitor combination which is amongst the most prescribed antimicrobials in hospital ...
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Abstract Introduction: Pleural empyema is the collection of pus within the pleural cavity, typically arising as a complication of pneumonia, chest trauma, thoracic surgery, or bact...
Prevalence of Piperacillin-Tazobactam induced Hypersensitivity Reaction in Workers of Stallion’s Pharmaceutical Factory at Lahore
Prevalence of Piperacillin-Tazobactam induced Hypersensitivity Reaction in Workers of Stallion’s Pharmaceutical Factory at Lahore
BACKGROUND & OBJECTIVE: Piperacillin is an antibiotic that belongs to the ureidopenicillin family. Piperacillin-tazobactam provides cover against gram-positive, gram-negative b...
P08 An usual case of pandrug-resistant Serratia marcescens in a 63 year-old-male: a case report
P08 An usual case of pandrug-resistant Serratia marcescens in a 63 year-old-male: a case report
Abstract Objectives To highlight the growing burden of antimicrobial resistance in developing countries where there are no offic...
Comparison of the Pharmacokinetics of Piperacillin and Sulbactam during Intermittent and Continuous Intravenous Infusion
Comparison of the Pharmacokinetics of Piperacillin and Sulbactam during Intermittent and Continuous Intravenous Infusion
<i>Background:</i> The antibacterial effect of piperacillin/sulbactam depends on the time of drug concentration above the minimal inhibitory concentration (MIC). Theref...

Back to Top